Magritek

Founded by Sir Paul Callaghan, Magritek makes benchtop nuclear magnetic resonance (NMR) solutions, measuring the chemical properties of substances for research and industry.

As a world leader in the field, Magritek brought the first desk top NMR spectrometer to the market in 2012.

Rangatira is invested alongside management, employees, Ampersand Capital (US healthcare tech investor) and other shareholders. In 2023, Ampersand increased their stake to 20%.

Website

Investment Date  2013

Ownership Interest  24%

Primary Contact   Mark Dossor